Sierra Oncology (NASDAQ:SRRA) Stock Rating Upgraded by Zacks Investment Research

Retrieved on: 2018-09-01 20:33:45

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (NASDAQ:SRRA) Stock Rating Upgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc purchased a new stake in shares of Sierra Oncology in the 1st quarter worth approximately $203,000. Finally, Fred Alger ...</div>

Article found on:

View Original Article